Press "Enter" to skip to content

New patent expiration for Covis Pharma drug OMNARIS

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Covis Pharma drug OMNARIS

Annual Drug Patent Expirations for OMNARIS
Annual Drug Patent Expirations for OMNARIS

Omnaris is a drug marketed by Covis Pharma Bv and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.

OMNARIS drug price trends.

This drug has ninety-seven patent family members in thirty-six countries.

The generic ingredient in OMNARIS is ciclesonide. One supplier is listed for this compound. Additional details are available on the ciclesonide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Covis Pharma drug OMNARIS

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!